Use of depth filters to remove prion infectivity from plasma - derived therapeutic products and/or other biologics. Depth Filtration is a chemically inactive process and therefore does not introduce potentially toxic bi-products or alter components. More

Proprietary manufacturing process for a liquid IVIgG product - in great demand world-wide as one of the principal therapeutics obtained from blood plasma. Process delivers a low IgA content, which increases renal tolerability. More

Proprietary process to produce a freeze-dried fibrinogen therapeutic product, easily soluble. Includes two virus inactivation processes: dry heat treatment and solvent/detergent. More

A new excitation pulse sequence for the acquisition of Magnetic Resonance Imaging (MRI) data of particular usefulness in Magnetic Resonance Angiography (MRA). More

Novel process for production of thrombin and thrombin preparations capable of being produced in a freeze dried form, which may be heat-treated to inactivate any viruses present. More

The University of Edinburgh has discovered a binding site for zinc in human albumin. More

The invention teaches a step - charge in yielding improvement over the Cohn process, widely applicable to immunoglobulin manufacture. More

Using a groundbreaking technique developed in astronomy, researchers at the University of Edinburgh are able to register complete 3D image volumes to sub-pixel accuracy in real-time More

Researchers at the University of Edinburgh have developed screening techniques that are able to identify if a patient has been exposed to a multiple organ failure initiating event, or is likely to develop multiple organ failure. More